male predominance, increased risk of familial heritability and higher rate of concomitant atopic disorders [2] [3] [4] . Currently, EoE is the most common cause of dysphagia and food impaction in children and adults under 50 years-old [2, 3] . The reasons for the rapid increase in incidence and prevalence of EoE, especially over the past decade, remain unclear.
Helicobacter pylori (H. pylori) infects approximately 50% of the global population, with a wide variation between regions and countries [5] . Prevalence is highest in Africa, Latin America, and Asia (54-80%), but lowest in Northern Europe, Northern America and Oceania (16-37%) [5] . Primary infection mostly occurs during childhood and inadequate sanitation practices, low social class, and crowded or high-density living conditions seem to be related to a higher prevalence of H. pylori infection [5] . H. pylori colonizes gastric mucosa and usually elicits a gastric Th1/Th17 type of immune response [6] . Since its formal characterization in the early 1980s and subsequent association with several conditions (peptic ulcer disease, chronic gastritis, gastric cancer, and MALT lymphoma), H. pylori prevalence has markedly decreased in westernized countries [e.g., United States (28%) [7] , Japan (18%) [8] , Sweden (15%) [9] ].
Therefore, an inverse association between rising EoE and declining H. pylori patterns has been repeatedly reported in literature over the past five years [10] [11] [12] [13] [14] . The rationale behind this association, proven in a murine model [15] , is that the immunomodulatory properties of H. pylori, polarizing the immune system towards a Th1 response, may confer protection against Th2-mediated allergic disorders. As such, a protective role of H. pylori infection against the development of EoE has been suggested. Because of the limited number of studies and potential methodological issues (retrospective design, small sample size, inadequate H. pylori diagnostic methods), prospective large-scale multicenter studies are still required to clarify the proposed association between H. pylori and EoE. We aimed to further investigate this association through a large multicenter prospective and controlled evaluation of H. pylori status in EoE patients.
MEthodS
This study was a prospective multicenter case-control study conducted in Spain (16 centers), Italy (5 centers), France (1 center), and Colombia (1 center) from December 2014 to January 2017. All patients gave their written informed consent for endoscopic procedures and study enrolment. The investigations were conducted according to the principles expressed in the Declaration of Helsinki. Approval from the Institutional Review Board was obtained from each participating institution.
Patients
Consecutive patients older than 2 yrs-old with a diagnosis of EoE, defined by updated evidence-based guidelines [2] (symptoms of esophageal dysfunction plus ≥ 15 eosinophilis per high power field (eos/HPF) in esophageal biopsies) and naïve to EoE therapy were eligible for enrollment. Patients were recruited from outpatient gastroenterology clinics or endoscopy suites. Symptoms of esophageal dysfunction were food refusal, reflux-like symptoms, vomiting, abdominal pain for toddlers and young children and food impaction, dysphagia, heartburn and chest pain for older children, adolescent and adults [2] .
Controls
Controls were required to be individuals who also were undergoing upper endoscopy, mostly due to suspicion of EoE, in whom esophageal biopsies were obtained. Accordingly, the control group was made up of consecutive patients older than 2 yrs-old with similar symptoms of esophageal dysfunction but eosinophilic inflammation < 5 eos/HPF in esophageal biopsies taken during endoscopic procedures.
Assessment of clinic, endoscopic, and histologic data
For all included cases and controls, data on demographics (age, gender, smoking habit), atopic background, symptoms of esophageal dysfunction, endoscopic features of EoE (rings, furrows, exudates, edema, strictures, narrow caliber esophagus, crepe paper esophagus) [16] , the presence of distal erosive esophagitis, graded according to Los Angeles classification, and histological features (peak proximal and peak distal eosinophil counts) at the index endoscopy were obtained. Atopy in both groups was defined by the presence of any of the following disorders: asthma, rhinoconjunctivitis, food allergy, oral allergy syndrome, atopic dermatitis, anaphylaxis, urticaria or angioedema, registered in clinical records and diagnosed by an allergy specialist.
All endoscopic procedures were performed with either topic pharyngeal anesthesia or propofol-based sedation, according to patient preference, by board-certified gastroenterologists and pediatricians. Using conventional grasping forceps, at least six biopsy specimens were taken separately from the distal and proximal esophagus. Mucosal biopsy specimens were fixed in formalin, embedded in paraffin, and stained with hematoxylin and eosin for histologic examination, performed by senior gastrointestinal pathologists with expertise in EoE at each center. Peak eosinophil count was determined in the area of highest density of eosinophils and esophageal eosinophilia was defined upon the presence of 15 or more eos/HPF in at least one field [1, 2] .
Data collection
Study data were collected and managed using REDCap electronic data capture tools hosted at the Spanish Gastroenterological Association (AEG): AEG-REDCap (https://redcap.aegastro.es/) [17] . REDCap (Research Electronic Data Capture) is a secure, webbased application designed to support data capture for research studies, providing: (1) an intuitive interface for validated data entry; (2) audit trails for tracking data manipulation and export procedures; (3) automated export procedures for seamless data downloads to common statistical packages; and (4) procedures for importing data from external sources.
H. pylori status
All included individuals, both cases and controls, were required to be naïve for H. pylori eradication therapy. EoE patients and controls with previous eradication regimens for H. pylori were excluded. [18] . When rapid urease test was selected as diagnostic test, one biopsy was taken from the corpus and one from the antrum. As for histology, two biopsies from each location were taken. In patients with negative invasive tests, a 13 C-UBT or monoclonal stool antigen test was recommended to further exclude H. pylori infection. If patients were on active PPI therapy during the endoscopic procedure, a further non-invasive test off PPI therapy was performed.
Eradication of H. pylori infection was defined as a negative 13 C-UBT with citric acid at least 4 weeks after completion of treatment. 13 C-UBT was performed after an overnight fast and PPI discontinuation at least 2 weeks before [18] .
Management of EoE
According to the current guidelines [2] , patients were classified as responders to PPI therapy when they achieved symptom improvement and histologic remission, defined by <15 eos/HPF, after an 8-week course of double-dose PPI therapy. In patients unresponsive to PPI therapy, dietary or topic swallowed steroids were offered.
Endpoints
The primary endpoint of the study was to assess the prevalence of H. pylori infection in a large cohort of pediatric and adult EoE patients, compared to a group of symptomatic controls. Secondary aims were to evaluate differences in terms of H. pylori prevalence between children and adults, atopic and non-atopic and responders and non-responders to PPI therapy.
Statistical analysis
The SPSS 21.0 (IBM, Armonk, NY) statistical analysis package was used. Categorical variables were described with percentages and continuous variables were described with mean (standard deviation) or median (range), as appropriate. Associations between categories were tested with χ 2 (with Fisher's correction when necessary) and continuous data were assessed using the two-sample t-test or the Mann-Whitney U, for parametric and non-parametric data, respectively. For multiple comparisons, analysis of variance and Student-Newman-Keuls multiple comparisons were performed. A multiple logistic regression analysis was performed using variables with P < 0.1 in the univariate analysis. We used a backward modeling strategy, and the log likelihood ratio was used for model comparison. The magnitude of the effect is described with an odds ratio (OR) and 95% confidence interval (CI). P values < 0.05 were considered statistically significant. With previous studies reporting a 3.2% maximum difference in H. pylori prevalence between cases and controls, a sample size of 830 patients was required to be 90% sure than the limits of a two-sided 90% CI will exclude a difference between groups of more than 3.2.
rESuLtS

Baseline characteristics
From an initial set of 1243 eligible individuals, a total of 808 (404 cases, 404 controls) were included in the study, of whom 170 ship. EoE was first described in the early 90s [19] and since, incidence and prevalence have steadily grown [2, 3] . Conversely, H. pylori eradication regimens were also developed during the early 90s [20, 21] and their latter widespread use has been shown enormously effective to reduce peptic ulcer disease [22] and gastric cancer incidence in high-risk populations [23] . A weak inverse association between H. pylori and atopy and rhinitis was observed in the present study, but this could not be demonstrated for asthma or food allergy. In line with our findings for EoE, meta-analyses and studies questioning the inverse association between H. pylori infection and atopic disorders have lately been reported [24] [25] [26] [27] . More specifically, discrepant results have been lately reported in studies and meta-analyses regarding the proposed inverse association between asthma and H. pylori infection, supporting [28] [29] [30] [31] [32] [33] or discarding [34] [35] [36] this hypothesis. A more recent review on this topic has suggested that H. pylori, rather than providing protection against atopic conditions, may merely be a marker of socio-economic status and hygiene, well known to be also directly associated with atopic conditions [37] . Therefore, rising allergic disorders may be influenced by a more general change in human microecology, like gut microbiota alterations related to better hygiene, antibiotic use, and changes in dietary habits. In this complex scenario, H. pylori declining is likely to represent a mere epiphenomenon [38] . Two recent studies conducted in Finland and The Netherlands have shown conflicting inverse or positive associations depending on either ethnic background or socioeconomic environment, hinting at the existence of potentially missed confounders driving this association [35, 39] . Likewise, numerous methodological deficiencies were identified in previous case-control studies suggesting an inverse association between H. pylori infection and EoE [11] [12] [13] [14] (Table 3) . The two biggest studies, from the same group of researchers [11, 14] , performed a retrospective analysis of pathological databases. However, the protocol for taking gastric biopsies was not provided [11] (or stated that only 3.9% of biopsy sets were Sydney System compliant [14] ), and no information on previous PPI discontinuation before biopsies was available. These data about PPI withdrawal were not provided in the remaining study, which also used histology as a diagnostic test [12] .Therefore, there might be concerns about H. pylori false negatives in these studies. In the first big studies [10, 11] , cases were defined by any esophageal eosinophilia, without using the specific histological threshold of 15 eos/HPF. Additionally, data on previous eradication regimens [10] [11] [12] [13] [14] or esophageal symptoms [10] [11] [12] [13] [14] were missing in some patients. As for the latest prospective study, a small sample size, the use of serology as a diagnostic test for H. pylori infection and the lack of esophageal biopsies in the control group question the reproducibility of these results. Validated IgG antibodies cannot discriminate whether H. pylori infection is present or past, and this may result in a significant proportion of false positives. In this regard, a protective role for H. pylori can only be possible via early colonization, that would eventually protect against further development of allergic disorders during the adulthood. However, by using serology and limiting included patients to adults, one cannot truly ascertain this temporal association.
More importantly, the majority of these studies found an extremely low prevalence of H. pylori infection, ranging from 3 to 8.6% in EoE cases [11] [12] [13] [14] , excepting the Kalixanda study (16%) [10] . In a recent comprehensive meta-analysis assessing the global prevalence of H. pylori infection, the lowest H. pylori prevalence rates were reported in Switzerland (18.9%), Denmark (22.1%), New Zealand (24.0%), Australia (24.6%), and Sweden (26.2%) [23] . Even these lowest figures are five to ten times higher than the prevalence estimated for H. pylori in the four previous casecontrol studies [11] [12] [13] [14] . In the aforementioned meta-analysis, estimates for prevalence of H. pylori infection in Western Europe and North America were 34.3% and 37.1%, respectively [23] . As such, our overlapping prevalence rates in the present study (37% cases, 40% controls) match much more with a realistic scenario for H. pylori infection, compared to previous case-control studies [10] [11] [12] [13] . Prevalence data in Spain and Italy were estimated to be 56 and 55% in the aforementioned meta-analysis [23] , but were around 40% in the present study, in line with recent studies suggesting a progressive declining in H. pylori prevalence in developed countries [7] [8] [9] . Our study also first assessed a similar lack of association between H. pylori and EoE in both responders and non-responders to PPI therapy. This finding is an additional argument supporting the lack of relevant differences between EoE patients responders and non-responders to PPI therapy, whom should be all included within the EoE spectrum [2] . Strengths to the present study include a large number of cases and control prospectively recruited at multiple centers, including both children and adults, exclusion of patients with previous H. pylori eradication treatments, protocolized esophageal and gastric biopsies in both cases and controls, detailed clinical information and adequate previous PPI discontinuation before H. pylori testing, widening the diagnostic approach with non-invasive testing. As for potential limitations, concerns with the control group should be acknowledged. Atopy (31%), rhinitis (26%), and asthma (18%) in controls were much more common than that expected for a standard healthy population. Control group was made up of symptomatic patients with minimal to no esophageal eosinophilia on esophageal biopsies, so a potential explanation is that increasing index of suspicion for EoE has led to more endoscopy referral in atopic patients with any kind of upper gastrointestinal symptom, especially epigastric/ abdominal pain. No specific questionnaires were used to evaluate EoE symptoms and different diagnosed means were utilized to test H. pylori infection, which might have biased the comparative analysis.
In conclusion, no inverse relationship was observed between H. pylori infection and EoE in a large prospective multicenter casecontrol study. Similarly, a borderline association was observed for atopy and allergic rhinitis, but not for asthma or food allergy. In line with recent evidence, our findings question a true protective role of H. pylori infection against allergic disorders. Therefore, H. pylori infection may merely act as a weak surrogate for socio-economic status and hygiene, rather than modulate the immune host response. Opposite to the H. pylori infection hypothesis, we speculate that evolving environmental and microbial exposures, microbiota changes related to better hygiene, antibiotic use or dietary habits, as well as differences in ethnicity and socioeconomic conditions, are likely more plausible reasons to understand the rising trends of atopic conditions over the past two decades.
